Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2013
10/24/2013US20130281434 Therapeutic compounds
10/24/2013US20130281402 Hdac inhibiting derivatives of camptothecin
10/24/2013US20130281396 Treatment of diseases by epigenetic regulation
10/24/2013US20130280305 Cationic lipid
10/24/2013CA2850881A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/23/2013EP2651952A2 Polymorphic forms of asenapine maleate and processes for their preparation
10/23/2013EP2651951A1 Tricyclic pi3k inhibitor compounds and methods of use
10/23/2013EP2651931A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
10/23/2013EP2651891A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
10/23/2013CN103361276A Saccharopolyspora spinosa HBERC-25376, culturing method thereof as well as separation method and application of active substances thereof
10/23/2013CN103360402A Salt of methoxysanguinarine derivative
10/23/2013CN103360401A Salts of methoxyl dictamnine derivatives
10/23/2013CN103360400A Salt for skimmianine derivates
10/23/2013CN103360395A Indole carbazole compound as well as preparation method and application thereof
10/23/2013CN103360358A 15-oxospiramilactone derivatives, and preparation method and applications thereof
10/23/2013CN103360327A Benzophenazine derivative, as well as preparation method and application thereof
10/22/2013US8563723 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
10/22/2013CA2538146C Pyridomorphinans, pyridazinomorphinans and use thereof
10/17/2013WO2013154712A1 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
10/17/2013WO2013154325A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
10/17/2013WO2013154173A1 Amidopyridine derivative, and use thereof
10/17/2013WO2013153535A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
10/17/2013WO2013152717A1 Fused pyrimidine compound, and preparation method, intermediate, composition， and uses thereof
10/17/2013US20130274483 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
10/17/2013US20130274466 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
10/17/2013US20130274464 Arylethynyl Derivatives
10/17/2013US20130274304 Chemical Compounds
10/16/2013EP2650284A1 Heterocyclic derivatives as metabotropic glutamate receptor modulators
10/16/2013EP2649078A1 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
10/16/2013EP2649065A1 Bicyclic compounds as pim inhibitors
10/16/2013EP2649064A1 Novel triazole compounds iii
10/16/2013CN103351393A Reducing agent for preparing Asenapine and preparation method of Asenapine
10/16/2013CN102617584B Irinotecan hydrochloride compound and medicinal composition thereof
10/16/2013CN102532021B Preparation method of 2-alkoxy-3,4-disubstituted isoquinoline-1(2H)-one derivatives
10/16/2013CN102399228B Preparation method of N-alkyl polyhydroxypiperidine derivative
10/16/2013CN101490055B Spirocyclic azaindole derivatives
10/15/2013US8557808 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/15/2013US8557765 Spatially-defined macrocycles incorporating peptide bond surrogates
10/10/2013WO2013150993A1 Pharmaceutical for preventing or treating gingivitis
10/10/2013WO2013149996A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149903A1 N- substituted hetero - bicyclic furanone derivatives for combating animal
10/10/2013WO2013149581A1 Combination products with tyrosine kinase inhibitors and their use
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267574 Polymorphic Forms of Asenapine Maleate and Processes for their Preparation
10/10/2013US20130267521 Heterocyclic compounds and uses thereof
10/10/2013US20130267501 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
10/10/2013US20130267496 Imidazopyrazine syk inhibitors
10/10/2013US20130266563 Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof
10/09/2013EP2647638A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/09/2013CN103347865A Herbicidal compound
10/09/2013CN103347859A Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
10/09/2013CN103342707A Preparation method for preparing asenapine intermediate
10/09/2013CN101801954B Compounds and compositions as modulators of GPR119 activity
10/08/2013US8552183 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
10/08/2013US8552181 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
10/08/2013US8552054 Anticancer agents, viricides, psychological disorders
10/08/2013US8552018 Substituted tricyclic compounds as protein kinase inhibitors
10/08/2013US8551985 Carbinol derivatives having heterocyclic linker
10/08/2013US8551982 Benzodioxane inhibitors of leukotriene production
10/08/2013US8551981 Furo[3,2-d]pyrimidine compounds
10/08/2013US8551965 Anti-viral pyrimidine nucleoside analogues
10/08/2013CA2706171C Fused indane compound
10/03/2013WO2013147117A1 Fused azole derivative
10/03/2013WO2013146969A1 Novel disubstituted cyclohexane derivative
10/03/2013WO2013143466A1 Substituted pyrimidine derivative as aurora kinase inhibitor
10/03/2013WO2013088452A3 Quinoline derivatives as renin inhibitors
10/03/2013US20130261104 Methods of use of diazacarbazoles for treating cancer
10/03/2013US20130259830 Crth2 modulators
10/02/2013EP2644618A1 tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators
10/02/2013EP2643325A1 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
10/02/2013EP2643311A1 Bicyclic gpr119 modulators
10/02/2013CN103339110A Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
10/02/2013CN103333676A Selenium ion fluorescent probe, and preparation method and application thereof
10/02/2013CN103333172A Camptothecin thiosemicarbazone compound and preparation method and use thereof
10/02/2013CN102321094B New Gelsmium elegans Benth. alkaloid compound as well as preparation method and application thereof
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/01/2013US8546422 Azaindole derivatives as CRTH2 receptor antagonists
10/01/2013US8546420 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/01/2013US8546410 Heteroaryl-fused macrocyclic pyrimidine derivatives
10/01/2013US8546379 5HT2C receptor modulators
10/01/2013US8546376 Pharmaceutical compounds
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
09/2013
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013140189A1 6- (4- (1 -amino- 3 -hydroxycyclobutyl) phenyl) - 5 - phenyl (furo, thieno or pyrrolo) [2, 3-d] pyrimidin- 4 - one derivatives for the treatment of cancer
09/26/2013WO2013140148A1 Quinazoline compounds and their use in therapy
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130252999 2-phenyl-4-quinolones as anticancer agents
09/26/2013US20130252992 Cyclic n,n'-diarylthiourea - androgen receptor antagonist, anti breast cancer composition and use thereof
09/26/2013US20130252969 Compounds
09/26/2013US20130252962 Spiro-oxindole compounds and their use as therapeutic agents
09/26/2013US20130252961 Macrocyclic derivatives for the treatment of diseases
09/26/2013US20130251647 Low molecular weight modulators of the cold menthol receptor trpm8 and use thereof
09/25/2013EP2641907A1 Preparation of modulators of 5-HT receptors
09/25/2013EP2640727A1 Alaninyl maytansinol antibody conjugates
09/25/2013EP2640726A1 Novel compound for organic electronic material and organic electroluminescent device using the same
09/25/2013EP2640719A2 Antiviral compounds
09/25/2013EP2640705A2 Novel antiviral compounds
09/25/2013EP2640392A2 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
09/25/2013CN103328480A Condensed imidazolylimidazoles as antiviral compounds
09/25/2013CN103328463A Chromene derivatives and their analoga as wnt pathway antagonists
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 298